Last Update16 Oct 25Fair value Increased 1.44%
Analysts have raised their price target for Carlyle Group from $68.08 to $69.06 per share. They cited improved revenue growth expectations and a modest reduction in implied risk, even as profit margin forecasts were slightly lowered.
What's in the News
- Executive transition announced: John C. Redett will become Co-President of Carlyle and lead Global Private Equity starting January 1, 2026. Justin Plouffe will take on the role of Chief Financial Officer on the same date.
- Carlyle completed a buyback tranche, repurchasing 2,173,966 shares worth $100.04 million from April 1 to June 30, 2025. The total buyback under the ongoing program now stands at 23,084,100 shares for $909.85 million.
- Carlyle is considered among a group of private equity investors, including Temasek and ChrysCapital, in discussions to acquire a minority stake in Bengaluru-based Nash Industries, which is raising $120-150 million.
Valuation Changes
- Consensus Analyst Price Target has increased from $68.08 to $69.06 per share, reflecting a modest upward revision.
- Discount Rate has risen slightly from 9.28% to 9.39%, indicating a marginally higher risk premium.
- Revenue Growth projections have improved, with the decline moderating from -2.64% to -1.54%.
- Net Profit Margin forecast has decreased from 33.26% to 32.15%.
- Future P/E ratio has edged higher, moving from 19.59x to 19.94x.
Key Takeaways
- Diversified products, global expansion, and partnerships are broadening Carlyle's investor base, strengthening recurring revenues, and supporting long-term growth.
- Strong performance in private credit, secondaries, and technology-driven investments boosts earnings stability and reduces dependence on cyclical fundraising activities.
- Heightened competition, regulatory pressures, and strategic expansion risks threaten Carlyle's profitability, earnings stability, and ability to sustain fee and asset growth.
Catalysts
About Carlyle Group- An investment firm specializing in direct and fund of fund investments.
- Expanding global wealth and broader retail investor participation-including new evergreen products (e.g., CAPM, CPEP) and strategic partnerships (e.g., UBS)-are driving robust and recurring fundraising, positioning Carlyle to further broaden its AUM base and capture a greater share of the growing demand for private market solutions, which is likely to boost fee revenues and long-term earnings growth.
- Surging institutional allocations to alternatives, reinforced by significant momentum in areas like private credit and asset-based finance (with AUM up 40% YoY), as well as a growing insurance channel (notably Fortitude Re and reinsurance flows), increasingly diversify Carlyle's revenue streams and enhance margins by providing higher recurring, stable fee income across cycles.
- Ongoing technological innovation and digital transformation across industries are fueling strong investment activity and deal flow, as evidenced by deployment growth (up nearly 50% YoY) and high appreciation in recent buyout funds, which is likely to support robust realization activity and performance-related fee growth, driving upside to earnings and cashflows.
- Geographic expansion (notably in Asia and the Middle East) and strengthening of global partnerships both in Wealth and Institutional channels are unlocking new client segments and markets, accelerating organic AUM growth and supporting more resilient management fee revenues.
- Persistent growth and strong investment performance in the secondaries/co-investment and perpetual capital strategies, coupled with innovation in capital markets activities, are increasing Carlyle's earnings stability and potential for margin expansion by reducing reliance on episodic fundraising or realization cycles.
Carlyle Group Future Earnings and Revenue Growth
Assumptions
How have these above catalysts been quantified?- Analysts are assuming Carlyle Group's revenue will decrease by 2.6% annually over the next 3 years.
- Analysts assume that profit margins will increase from 22.7% today to 33.3% in 3 years time.
- Analysts expect earnings to reach $1.7 billion (and earnings per share of $4.93) by about September 2028, up from $1.3 billion today.
- In order for the above numbers to justify the analysts price target, the company would need to trade at a PE ratio of 19.6x on those 2028 earnings, up from 18.3x today. This future PE is lower than the current PE for the US Capital Markets industry at 26.7x.
- Analysts expect the number of shares outstanding to grow by 1.12% per year for the next 3 years.
- To value all of this in today's terms, we will use a discount rate of 9.28%, as per the Simply Wall St company report.
Carlyle Group Future Earnings Per Share Growth
Risks
What could happen that would invalidate this narrative?- Increasing competition from other private equity and alternative asset managers could put downward pressure on Carlyle's management and performance fees, directly impacting long-term revenue growth and net margins.
- Persistent elevated interest rates or a reversal of the current benign credit environment could raise borrowing costs for leveraged deals, compressing investment returns and fee income, thereby threatening future earnings growth.
- Regulatory changes or tightening-such as disclosure requirements, ESG mandates, or global compliance costs-may raise operational expenses and constrain Carlyle's flexibility to pursue certain deals, weighing on both profitability and earnings stability.
- Overreliance on continued fundraising momentum, especially in key growth areas like wealth management and secondaries, exposes Carlyle to cyclicality risks; a downturn in investor appetite or poor fund performance could stall AUM growth and suppress future fee earnings.
- The rapid expansion into new business lines (e.g., insurance, wealth, perpetual capital vehicles) and geographies carries execution and integration risks, which could introduce inefficiencies or higher costs, negatively impacting net margins and overall profitability.
Valuation
How have all the factors above been brought together to estimate a fair value?- The analysts have a consensus price target of $68.083 for Carlyle Group based on their expectations of its future earnings growth, profit margins and other risk factors. However, there is a degree of disagreement amongst analysts, with the most bullish reporting a price target of $80.0, and the most bearish reporting a price target of just $56.0.
- In order for you to agree with the analyst's consensus, you'd need to believe that by 2028, revenues will be $5.1 billion, earnings will come to $1.7 billion, and it would be trading on a PE ratio of 19.6x, assuming you use a discount rate of 9.3%.
- Given the current share price of $63.63, the analyst price target of $68.08 is 6.5% higher. The relatively low difference between the current share price and the analyst consensus price target indicates that they believe on average, the company is fairly priced.
- We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.
How well do narratives help inform your perspective?
Disclaimer
AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.



